腎臓細胞がんにおける非コーディングRNAとオートファギーの交響:分子経路の解読と治療の見通し
Mina Alimohammadi1, Mojgan Noroozi2, Alireza Mafi3,4
1Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Cancer cell international
|September 2, 2025
まとめ
非コーディングRNA (ncRNA) は,腎臓がんにおける二重の役割を持つ細胞過程であるオートファギーを調節する. この相互作用を理解すると,腎臓細胞癌 (RCC) の新しい診断バイオマーカーと治療標的が明らかになる可能性があります.
科学分野:
- 腫瘍学
- 分子生物学
- 生物化学
背景:
- 腎臓細胞癌 (RCC) は,しばしば進行した段階で診断される攻撃的な腎臓癌です.
- 伝統的な治療は限られた効果を示し,新しい分子標的を必要とします.
- 細胞の分解プロセスであるオートファギーは,RCCにおいて複雑な役割を果たし,腫瘍抑制剤とプロモーターの両方として作用する.
研究 の 目的:
- 非コーディングRNA (ncRNA) と腎臓細胞癌 (RCC) の自己死性の相互作用に関する現在の理解をレビューする.
- RCCの病原化に関与する特定のncRNAとその調節メカニズムを特定する.
- RCCの診断バイオマーカーと治療標的としてのncRNAとオートファギーの可能性を評価する.
主な方法:
- ncRNA,オートファジー,RCCに関する現在の知識を統合した文献レビュー.
- 分子スポンジ,スキャフォールド,および転写調節体としての役割を含むncRNAの調節機構の分析.
- PI3K/AKT/mTOR,AMPK,p53,KEAP1/NRF2などのオートファジーにおけるncRNAによって調節される信号経路の検査
主要な成果:
- 長いncRNAsとmicroRNAs (miRNAs) を含むncRNAsは,RCCにおけるオートファギーの主要な調節因子である.
- これらのncRNAはオートファジーに関連する遺伝子発現に影響を与え,重要なシグナル伝達経路を調節する.
- ncRNAsは,自己滅菌活動を強化または抑制し,腫瘍の進行,転移,および治療抵抗性に影響を与える.
結論:
- ncRNAとオートファギーの間のクロストラックは,RCCの病原性において極めて重要です.
- 特定のncRNAは早期発見と予後のための診断バイオマーカーとしての可能性を秘めています.
- ncRNA- 自閉症の相互作用をターゲットにすることで,個別化されたRCC治療のための新しい治療戦略を提供することができる.
- これらの分子相互作用に関するさらなる研究は,RCC患者の臨床結果を改善することができます.
関連する概念動画
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
Autophagy
4.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.6K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K


